Oncology clinical trial nurse navigator Elise Curry, RN, explains the impact of the FDA's approval of oral iberdomide for multiple myeloma.
Elise Curry, BA, BSN, RN, OCN
Advertisement
Articles by Elise Curry, BA, BSN, RN, OCN
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Prostate Cancer Risk Factors Do Not Predict Hormone Therapy Benefit
2
FDA Approves Iberdomide for Relapsed or Refractory Multiple Myeloma
3
Advancing Frontline Treatment in Metastatic Triple-Negative Breast Cancer with ADCs
4
Understanding the Frontline Landscape of Metastatic Triple-Negative Breast Cancer
5